Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel
Abstract Introduction Hallucinations and delusions present with psychosis are debilitating non-motor symptoms of Parkinson’s disease, with a prevalence of up to 50–70% at some point during the course of the disease. Often patients and caregivers do not report the presence of hallucinations or delusi...
Main Authors: | Rajesh Pahwa, Stuart H. Isaacson, Gary W. Small, Yasar Torres-Yaghi, Fernando Pagan, Marwan Sabbagh |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2022-07-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40120-022-00388-y |
Similar Items
-
Approach to the management of psychosis in Parkinson’s disease
by: Abhishek Lenka, et al.
Published: (2019-01-01) -
Update on the treatment of Parkinson’s disease psychosis: role of pimavanserin
by: Combs BL, et al.
Published: (2017-03-01) -
Pimavanserin: A Truly Effective Treatment for Parkinson’s Disease Psychosis? A Review of Interventions
by: Heim B, et al.
Published: (2023-05-01) -
Long-term outcomes with pimavanserin for psychosis in clinical practice
by: Umer Akbar, et al.
Published: (2022-01-01) -
Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson’s disease psychosis in USA: a retrospective administrative claims database analysis
by: Krithika Rajagopalan, et al.
Published: (2023-12-01)